A large-scale RNAi screen in human cells identifies new components of the p53 pathway
- PMID: 15042092
- DOI: 10.1038/nature02371
A large-scale RNAi screen in human cells identifies new components of the p53 pathway
Abstract
RNA interference (RNAi) is a powerful new tool with which to perform loss-of-function genetic screens in lower organisms and can greatly facilitate the identification of components of cellular signalling pathways. In mammalian cells, such screens have been hampered by a lack of suitable tools that can be used on a large scale. We and others have recently developed expression vectors to direct the synthesis of short hairpin RNAs (shRNAs) that act as short interfering RNA (siRNA)-like molecules to stably suppress gene expression. Here we report the construction of a set of retroviral vectors encoding 23,742 distinct shRNAs, which target 7,914 different human genes for suppression. We use this RNAi library in human cells to identify one known and five new modulators of p53-dependent proliferation arrest. Suppression of these genes confers resistance to both p53-dependent and p19ARF-dependent proliferation arrest, and abolishes a DNA-damage-induced G1 cell-cycle arrest. Furthermore, we describe siRNA bar-code screens to rapidly identify individual siRNA vectors associated with a specific phenotype. These new tools will greatly facilitate large-scale loss-of-function genetic screens in mammalian cells.
Comment in
-
RNA interference: human genes hit the big screen.Nature. 2004 Mar 25;428(6981):375-8. doi: 10.1038/428375a. Nature. 2004. PMID: 15042071 No abstract available.
Similar articles
-
A resource for large-scale RNA-interference-based screens in mammals.Nature. 2004 Mar 25;428(6981):427-31. doi: 10.1038/nature02370. Nature. 2004. PMID: 15042091
-
A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.Genes Dev. 2002 Mar 15;16(6):681-6. doi: 10.1101/gad.929302. Genes Dev. 2002. PMID: 11914273 Free PMC article.
-
Comparisons of tumor suppressor p53, p21, and p16 gene therapy effects on glioblastoma tumorigenicity in situ.Biochem Biophys Res Commun. 2001 Sep 14;287(1):173-80. doi: 10.1006/bbrc.2001.5565. Biochem Biophys Res Commun. 2001. PMID: 11549271
-
Enzymatically prepared RNAi libraries.Nat Methods. 2006 Sep;3(9):696-700. doi: 10.1038/nmeth912. Nat Methods. 2006. PMID: 16929314 Review.
-
shRNA libraries and their use in cancer genetics.Nat Methods. 2006 Sep;3(9):701-6. doi: 10.1038/nmeth921. Nat Methods. 2006. PMID: 16929315 Review.
Cited by
-
Profile of Rene Bernards.Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2401063121. doi: 10.1073/pnas.2401063121. Epub 2024 Mar 4. Proc Natl Acad Sci U S A. 2024. PMID: 38437564 No abstract available.
-
Insulin signaling and pharmacology in humans and in corals.PeerJ. 2024 Jan 31;12:e16804. doi: 10.7717/peerj.16804. eCollection 2024. PeerJ. 2024. PMID: 38313028 Free PMC article.
-
Gaining New Insights into Fundamental Biological Pathways by Bacterial Toxin-Based Genetic Screens.Bioengineering (Basel). 2023 Jul 25;10(8):884. doi: 10.3390/bioengineering10080884. Bioengineering (Basel). 2023. PMID: 37627769 Free PMC article. Review.
-
Long noncoding RNA study: Genome-wide approaches.Genes Dis. 2022 Nov 29;10(6):2491-2510. doi: 10.1016/j.gendis.2022.10.024. eCollection 2023 Nov. Genes Dis. 2022. PMID: 37554208 Free PMC article. Review.
-
CUL4A silencing attenuates cervical carcinogenesis and improves Cisplatin sensitivity.Mol Cell Biochem. 2024 May;479(5):1041-1058. doi: 10.1007/s11010-023-04776-2. Epub 2023 Jun 7. Mol Cell Biochem. 2024. PMID: 37285039
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous